Summary
58 / 100 · Bulios Score
What speaks for it
- The share price is below the Bulios Fair Price.
- Revenue grew by 11% a year over the last 3 years.
What to watch
- Earnings per share fell by 6.6% a year over the last 3 years.
- It missed profit estimates 5 times in the last 8 quarters.
- Analysts expect revenue to fall by 8.7% this fiscal year.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 18.8 CHF for 1 CHF of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (CHF)
Diluted EPS (CHF)
- Analyst estimate
Revenue grew by 11% a year over 5 years. Over the last 3 years it grew by 11% a year. For the next fiscal year analysts expect revenue to fall by 8.7%. Earnings per share fell by 6.6% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Moderate, stretched- Yield
- 3.94%
- Paid out of profit
- 74%
- Raised in a row
- 1 year
You receive $3.33 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 1
- Hold 0
- Sell 0
No analyst has published a price target.
100% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.